Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gerd”

Showing 20 of 0 results

Not applicableStudy completedNCT00691743
What this trial is testing

Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2

Who this might be right for
Upper-GI Symptoms
AstraZeneca 850
Large-scale testing (Phase 3)Study completedNCT00839306
What this trial is testing

Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Eisai Inc. 240
Post-approval studies (Phase 4)UnknownNCT06430047
What this trial is testing

Efficacy and Safety of EsoDuo®

Who this might be right for
Gastro Esophageal Reflux
Chong Kun Dang Pharmaceutical 180
Not applicableStudy completedNCT03143608
What this trial is testing

GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery

Who this might be right for
Gastro Esophageal Reflux
Peter G Mavrelis 99
Not applicableStudy completedNCT01647958
What this trial is testing

The EndoGastric Solutions TEMPO Trial

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
EndoGastric Solutions 65
Early research (Phase 1)Study completedNCT01887743
What this trial is testing

Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study

Who this might be right for
ObesityGERD
Children's Mercy Hospital Kansas City 71
Not applicableStudy completedNCT01262755
What this trial is testing

Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology

Who this might be right for
Gastroesophageal Reflux DiseaseFunctional Bowel Disorders
Temple University 450
Not applicableEnrolling By InvitationNCT05216133
What this trial is testing

Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)

Who this might be right for
Airway DiseaseBarrett EsophagusGastroesophageal Reflux Disease
NYU Langone Health 200
Not applicableWithdrawnNCT03282084
What this trial is testing

A Prospective, Observational Study of the PPI Non-responder

Who this might be right for
Gastro Esophageal Reflux Disease PPI Non-Responders
Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07752407
What this trial is testing

Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks

Who this might be right for
Symptomatic Non-erosive Gastroesophageal Reflux Disease
Phathom Pharmaceuticals, Inc. 500
Not applicableStudy completedNCT00378898
What this trial is testing

Feasibility of Placing Bravo PH Capsule in Proximal Esophagus

Who this might be right for
Gastroesophageal Reflux Disease
Vanderbilt University Medical Center 39
Large-scale testing (Phase 3)Study completedNCT00251758
What this trial is testing

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Who this might be right for
Gastroesophageal Reflux Disease
Takeda 908
Not applicableUnknownNCT00516971
What this trial is testing

The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

Who this might be right for
Gastroesophageal Reflux
Hospital Authority, Hong Kong 200
Post-approval studies (Phase 4)Ended earlyNCT00537732
What this trial is testing

Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing

Who this might be right for
Gastroesophageal Reflux
Matthias Schwab 68
Large-scale testing (Phase 3)Study completedNCT02135107
What this trial is testing

Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

Who this might be right for
Gastroesophageal Reflux Disease
Eisai Co., Ltd. 517
Post-approval studies (Phase 4)Study completedNCT01397084
What this trial is testing

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Who this might be right for
Gastroesophageal Reflux DiseaseGERDReflux Esophagitis
AstraZeneca 107
Not applicableStudy completedNCT07722663
What this trial is testing

Endoscopic Classification of Fundoplication Integrity Predicts Pathologic Reflux

Who this might be right for
Gastro Esophageal Reflux
IRCCS Policlinico S. Donato 153
Post-approval studies (Phase 4)Ended earlyNCT01404832
What this trial is testing

The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors

Who this might be right for
Gastroesophageal Reflux DiseaseEosinophilic Esophagitis
Dallas VA Medical Center 102
Not applicableUnknownNCT03090607
What this trial is testing

Novel Endoluminal Clinical TreAtment of Reflux

Who this might be right for
GERD
Impleo Medical Inc. 100
Not applicableUnknownNCT00231881
What this trial is testing

Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux

Who this might be right for
Gastroesophageal Reflux
Nantes University Hospital 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation